Tissue Sealant Market | United States | 2018-2024 | MedCore
- Year: 2019
- Scope: 2015-2025
- Region: United States
- Pages: 524
- Type: MedCore
As the number of surgeries performed continues to increase year over year in the U.S., the need for medical sealants will grow accordingly. Over the forecast period, plant-based synthetics will grow in popularity, due to the potential risk of viral disease transmission inherent in plasma-derived products. In addition, price erosion in the synthetic market will encourage the switch to this increasingly affordable market.
Tissue sealants and glues are used in certain surgical procedures and for some types of bleeding to seal the edges of tissue together. Thus, tissue sealants can also be used to seal blood vessels, causing hemostasis. Even though some products are indicated only for tissue sealing, they can also be used off-label as a hemostat.
Segments Covered in This Market
- Fibrin-Based Tissue Sealant Market
- Protein-Based Tissue Sealant Market
- Synthetic Tissue Sealant Market
Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares
- Product Portfolios
- Related Press Releases from Top Competitors
Of the many companies in the United States Tissue Sealant market, Baxter was the leader, followed by Ethicon and Integra LifeSciences. In 2018, Baxter acquired Preveleak®, a protein-based tissue sealant, from Mallinckrodt plc. Preveleak® is used in vascular reconstruction and is made from bovine albumin serum and polyaldehyde. Ethicons fibrin sealant product, EVICEL®, is sourced from pooled human plasma. Integra was the leading competitor in the synthetic sealant market, with DuraSeal®. This product is indicated for intra-operative sealing of the dura, the outermost layer that protects the brain and spinal cord just under the bone.
About Our In-Depth MedCore Research
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.
This MedCore is also found in the full report suite titled United States Market Report Suite for Wound and Tissue Management – MedSuite
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.